Unite Genomics was honored to co-sponsor a recent webinar, Clinical Listening: Applying AI to Real-World Health Data to Improve Disease Understanding in Pharma.
Our CEO Taner Dagdelen joined Vivek Mukhatyar, Generative AI Medical Engagement Lead at Pfizer, Lance Hill, Chief Executive Officer at Within 3, and moderator Paulo Machado, Chief Executive Officer at Health Innovation Inc. for an insightful panel discussion designed for professionals in pharma medical affairs, medical analytics, and pharma commercial.
It’s an especially timely topic–physician adoption AI has surged 78% year over year, with 66% now actively using AI tools. And that’s just the tip of the iceberg. New AI-powered technologies are taking hold across the healthcare industry, from ambient listening technology to enterprise-wide AI solutions.
Our focus during this discussion was to understand who’s leading the charge in AI, and how medical affairs and commercial teams in pharma can identify the most valuable use cases.
Here are a few key takeaways:
If you weren’t able to join us live, we invite you to listen to the full webinar. Make sure to stay until the end, when our panelists share tips and best practices for deploying AI to unlock data insights and improve outcomes.
And, come back to our blog soon. We’ll be exploring these key takeaways in more depth in the coming months.
We invite you to listen to the full webinar:
https://stream.hubilo.com/389196/30779/258638/sb2RPTkAFWIWsRuIpdARbRZXHqhDCIwKOiNgtfGv00K8.mp4